Lung and skin hypersensitivity to 5-aminosalicylic acid.-Reference-Cited by-同舟云学术

Lung and skin hypersensitivity to 5-aminosalicylic acid.

Published:1991-04-20 Issue:6782 Volume:302 Page:970-970
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

le Gros V,Saveuse H,Lesur G,Brion N

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference6 articles.

1. Coated mesalazine (5-aminosalicvlic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial;Rachmilewitz, D.,1989

2. Sulphasalazine-induced lung disease;Jones, G.R.; Malone, D.N.S.;lThorax,1972

3. Rcspiratory disease duc to sulphasalazine;Thomas, P.; Seaton, A.; Edwards, J.;CinMAllergy,1974

4. Sulphasalazine-induced pulmonary disease;Moseley, R.M.; Barwick, K.W.; Dobuler, K.; Deluca, V.A.;Dig Dis Sci,1985

5. Severe allopurinol hypersensitivity;Young, J.L.; Boswell, R.B.; Nies, A.S.;Arch Intern Med,1974

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections;Journal of Clinical Medicine;2023-10-09

2. Mesalazine-induced lung injury with severe respiratory failure successfully treated with steroids and non-invasive positive pressure ventilation;Respiratory Medicine Case Reports;2020

3. A case report of mesalazine-induced lung injury: A reversible drug side effect;Respiratory Medicine Case Reports;2019

4. Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration: a case report and literature review;Therapeutics and Clinical Risk Management;2016-06

5. Tofacitinib for the treatment of ulcerative colitis;Expert Opinion on Investigational Drugs;2016-05-30